Alzheimer's drug shows long-term benefits in behavior and cognition. EU approval of Blarcamesine could boost its market value significantly. See more.

Dividend Aristocrats, firms with over 25 years of annual dividend growth, show their resilience through recessions, periods ...

President Donald Trump incorrectly placed the blame for high prescription drug prices in the U.S. on foreign nations, making ...

Local pharmacists said current tariff policies will make drugs more expensive and harder to find for consumers.

The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must ...

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take ...

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 ...

Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.

UnitedHealth's stock has tumbled 45.8% in 2025, enough to make it the S&P 500's worst performer this year. In comparison, the Health Care Select Sector SPDR ETF XLV has lost 5.2% this year and the S&P ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Joe Biden's "Inflation Reduction Act" didn't bring down prices – but it is poised to reduce the size of North Carolina's ...

Donald Trump’s tariff policies have been a hot mess since the day he decided to levy 25% tariffs on imports from Canada and Mexico,” writes columnist Jeffrey Scharf. “Things ...